Covid cases on the rise, experts call for newer drugs, faster approvals

The Drug Controller General of India had last week approved Merck and Ridgeback’s antiviral molnupiravir for the treatment of mild-to-moderate Covid-19 at high risk of developing into severe disease.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3sR6juT
via IFTTT